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The intestinal epithelium is constantly exposed 
to a multitude of foreign material that may ei-
ther be harmful or benefi  cial for the organism. 
Consequently, the intestinal immune system 
has to balance between either protective im-
mune responses that are induced upon encoun-
ter of intestinal pathogens and toxins or tolerance 
against commensal bacteria and food antigens. 
Inadequate protective immune reactions can 
cause severe immunopathology and are actively 
prevented in healthy individuals. Food antigens 
and commensal bacteria constitute the majority 
of the antigenic load in the intestine and the 
“default” reaction of the immune system con-
fronted with them leads to systemic unrespon-
siveness. This phenomenon is known as oral 
tolerance and represents a key feature of intesti-
nal immunity (1). The unique propensity of the 
intestinal immune system to evoke tolerance to 
orally administrated antigens off  ers attractive 
strategies to prevent or treat autoimmune dis-
eases (2, 3). Such approaches would exploit ef-
fective yet selective natural immunosuppressive 
mechanisms, thereby avoiding unwanted side 
eff  ects caused by an exhaustive and livelong 
treatment with immunomodulatory drugs.
The intestinal immune system is classi-
cally divided into eff  ector and inductor sites 
to emphasize the particular functions of both 
compartments. Inductive sites comprise orga-
nized lymphoid tissues in the intestinal mucosa 
(4) and the intestine draining mesenteric LNs 
(MLN). In contrast, intestinal eff  ector  sites 
consist of a network of immune cells scattered 
in a less organized fashion throughout the in-
testinal epithelium and lamina propria (LP). 
However, the role of these and further distal 
lymphoid and nonlymphoid compartments in 
the initiation and maintenance of oral tolerance 
remains elusive (1). This is exemplifi  ed by the 
ongoing discussion whether and how ingested 
antigens gain access to particular compartments 
and distribute throughout the body to trigger 
tolerance induction.
The original hypothesis that intestinal im-
mune responses exclusively depend on antigen 
uptake by M cells in Peyer’s patches (PP) epi-
thelium has been challenged by more recent 
reports that observed induction of oral   tolerance 
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in PP-defi  cient intestines (5–7). M cells have been identifi  ed 
in lymphoid aggregations other than PP (8) and even in his-
tologically inconspicuous villi (9), suggesting that a conclu-
sive study of M cell function for oral tolerance induction will 
have to consider additional M cell–competent structures other 
than PP.
In addition to the uptake of antigens by M cells in PP, 
some intestinal antigens appear to enter the LP where anti-
gens might be taken up by resident DCs that could present 
antigens both in situ in the LP as well as in the draining 
MLN. Indeed, LP DCs have been shown to present orally 
  applied antigens (10) and the majority of DCs entering the MLN 
appears to originate from the LP and not from PP (11, 12). 
Furthermore, DCs in the LP might directly contribute to 
  antigen uptake by extending dendrites through the epithe-
lium, thereby sampling luminal antigens (13). Importantly, 
antigen entering the LP might also disseminate via the cir-
culation and after antigen feeding intact food proteins have 
been reported to be present in minute amounts in serum of 
mice and   humans (14, 15), corroborating the general assump-
tion that distal compartments might contribute to oral toler-
ance induction.
In this study, we demonstrate that, after oral administra-
tion, the initial recognition of antigen is restricted to the in-
testinal immune system, in particular the MLN. Vice versa, 
we do not observe any overt signs of oral tolerance induction 
in peripheral LN (pLN) and spleen. Furthermore, we show 
that antigen recognition in the intestinal immune system is 
obligatory for oral tolerance induction and depends on CCR7-
mediated cell migration.
RESULTS
Interactions of antigen-presenting cells and naive T cells are 
thought to induce tolerance as well as immunity (16). Upon 
fi  rst-time encounter of an antigen, both conditions trigger 
the activation and clonal expansion of antigen-specifi  c T cells 
(17). Shortly thereafter, only T cells being activated under 
infl  ammatory conditions will continue to establish a protec-
tive immune response, whereas T cells expanded under tolero-
genic circumstances fail to gain classical eff  ector  functions. 
The fact that activated antigen-specifi  c T cells could be found 
throughout the immune system of antigen-fed animals, along 
with other observations, led to the hypothesis that tolerance 
induction is triggered simultaneously in all lymphoid organs 
(18, 19). Alternatively, proliferating T cells present in periph-
eral lymphoid tissues may have been primed in the intestinal 
immune system and subsequently emigrated to seed the 
  peripheral lymphoid tissues (20, 21).
Oral administration of antigen does not induce proliferation 
of antigen-specifi  c T cells in pLN and spleen 
in the presence of FTY720
Productive antigen recognition can be tracked in vivo by 
analyzing the induction of cell proliferation of adoptively 
transferred antigen-specifi  c T cells. Applying this experi-
mental system, we observe proliferation of antigen-specifi  c 
T cells in PP and MLN 2 d after antigen feeding. In spleen 
and other peripheral lymphoid organs, divided T cells appear 
1 d later and are abundantly present 4 d after antigen feeding 
(Fig. 1, not depicted, and  <CIT>references 18, 22 </CIT>).[ID]FIG1[/ID] To determine 
the potential sites of antigen recognition and T cell activa-
tion, we prevented the recirculation of lymphocytes by use 
of the immunomodulatory drug FTY720. FTY720 has been 
shown to interfere with sphingosine-1–phosphate receptor 
signaling that is essential for the emigration of lymphocytes 
from lymphoid organs into eff  erent lymphatics (23). There-
fore, FTY720-mediated shutdown of lymphocyte egress 
interrupts lymphocyte recirculation and causes a rapid induc-
tion of blood lymphopenia (24). In particular, lymphocyte 
egress from PP into the lymph connecting PP to the MLN is 
also shut down under FTY720 infl  uence (unpublished data), 
demonstrating that T cell proliferation in these two lymphoid 
compartments does not depend on T cell traffi   cking to the 
MLN. We observed that FTY720 treatment did not interfere 
with proliferation of adoptively transferred antigen-specifi  c 
transgenic T cells in PP and MLN after antigen feeding (Fig. 1
and not depicted). In contrast, proliferating T cells were 
Figure 1.  Oral administration of antigen does not induce prolif-
eration of antigen-specifi  c T cells in pLN and spleen in the presence 
of FTY720. 1 d after adoptive transfer of CFSE-labeled DO11.10 cells, 
wild-type recipients were fed 100 mg ovalbumin in PBS or PBS alone. 
Subsequently, mice were either treated with FTY720 (starting 16 h after 
antigen feeding) or mock treated. 2, 4, and 8 d after feeding of ovalbumin, 
mice were killed and proliferation of ovalbumin-specifi  c T cells was analyzed. 
Dot plots are gated on CD4-positve lymphocytes.JEM VOL. 203, March 20, 2006  521
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completely absent in pLN and spleen at all time points 
  analyzed (Fig. 1 and not depicted), identifying the intestinal
immune system as the genuine compartment of oral tolerance 
induction. To test for possible shortcomings in peripheral 
T cell    induction caused by FTY720 treatment, antigen 
was also given intravenously. Notably, T cell proliferation 
after systemic antigen administration was not infl  uenced by 
FTY720 treatment (unpublished data and  <CIT>reference 24 </CIT>), 
demonstrating an unimpaired capability of pLN and spleen 
to sustain a response to antigen under these conditions.
Recirculation of lymphocytes is dispensable for oral 
tolerance induction
We next analyzed the consequences of FTY720 treatment on 
the induction of functional oral tolerance. To this end, unma-
nipulated wild-type mice were continuously treated with 
FTY720 throughout the period of antigen feeding. Absence of 
freely disposable antigen as indicated by cessation of antigen 
presentation was verifi  ed experimentally before withdrawal of 
FTY720 (see Materials and methods). 9 d later, reestablish-
ment of normal peripheral blood lymphocyte counts was con-
fi  rmed and induction of tolerance was determined by measuring 
delayed type hypersensitivity (DTH) reactions. We observed 
signifi  cantly reduced DTH reactions in animals fed with anti-
gen compared with unfed controls irrespective of FTY720 
treatment (Fig. 2).[ID]FIG2[/ID These data suggest that antigen-specifi  c 
activation of lymphocytes in the intestinal immune system is 
suffi   cient for the induction of systemic unresponsiveness and 
that lymphocyte recirculation during antigen presentation is 
not required for the process of oral tolerance induction.
Tolerogenic potential is largely confi  ned to MLN
Because the MLN drain the small intestine, it is conceivable 
that these particular LNs play a pivotal role in the induction 
of oral tolerance. To test this hypothesis, we tolerized wild-
type mice under continuous FTY720 treatment and surgi-
cally removed the MLN before withdrawal of FTY720. 
Under these conditions, excision of the MLN almost com-
pletely prevented the establishment of systemic tolerance as 
indicated by DTH reactions observed in these mice (Fig. 3).
This fi  nding reveals that, even though proliferating T cells 
are present in PP, the majority of the tolerogenic potential 
Figure 2.  Recirculation of lymphocytes is dispensable for oral tol-
erance induction. Wild-type mice were fed four doses of 25 mg ovalbu-
min in PBS (black bars) or PBS alone (white bars) under continuous 
treatment with FTY720 (+FTY720) or mock treatment (−FTY720). Subse-
quently, on day 28, mice were immunized by subcutaneous injection of 
ovalbumin in PBS/CFA emulsion and challenged on day 41 (see Materials 
and methods). Tolerance induction was analyzed by measurement of DTH 
reactions 48 h after challenge. The experimental procedure is depicted in 
the fl  ow chart. #, control of peripheral blood cell counts to monitor 
FTY720-induced lymphopenia. Data shown have been obtained for 11 or 
12 mice in each group. Error bars represent SEM.
Figure 3.  Tolerogenic potential is largely confi  ned to MLN. Wild-
type mice were fed two doses of 25 mg ovalbumin under continuous 
FTY720 treatment and subsequently underwent surgical removal of MLN. 
Color images demonstrate absence of MLN in mice that underwent mesen-
teric lymphadenectomy (−MLN) compared with unmanipulated controls 
(+MLN). Arrows indicate (original) position of MLN. The experimental 
procedure is depicted in the fl  ow chart. #, control of peripheral blood cell 
counts to monitor FTY720-induced lymphopenia. Data shown have been 
obtained with 10 mice that underwent mesenteric lymphadenectomy and 
four mice in each of the unmanipulated control groups.  Error bars 
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was generated in the MLN and resided in this organ until its 
surgical removal. Furthermore, we also noted that mesenteric 
lymphadenectomy before antigen feeding counteracted oral 
tolerance induction (unpublished data).
Oral administration of antigen does not induce proliferation 
of antigen-specifi  c T cells in transplanted PP and MLN that 
are connected to the host circulation, but not to afferent 
lymphatics of the host intestine
To specifi  cally address the contribution of aff  erent lymphatic 
drainage to MLN function, we performed vascularized small 
bowel transplantations that included the draining MLN. In 
these mice, both the host and the graft MLN are connected 
to the blood circulation of the host, but the two types of 
MLN are distinguished by the fact that they receive aff  erent 
lymph in a mutually exclusive manner from their original 
  intestine only. These transplanted mice were adoptively 
transferred with TCR-transgenic T cells and challenged 
orally with antigen. After 2 d, we observed antigen-specifi  c 
T cell proliferation in PP and MLN of the antigen-challenged 
host intestine, but not in grafted PP or MLN, nor in pLN and 
spleen (Fig. 4). [ID]FIG4[/ID In contrast, intravenous administration of an-
tigen activated adoptively transferred T cells in both endo-
genous and transplanted PP and MLN (Fig. 4 and see next 
paragraph). In conclusion, our observations indicate that the 
grafted MLN react like distal pLN, and suggest a decisive role 
for antigen transport via lymphatic vessels from the intestine 
into draining MLN.
Mesenteric lymphadenectomy does not result in antigen 
recognition in peripheral lymphoid organs after oral 
administration of antigen
The precise role of passively drained antigen in comparison 
to cell-bound antigen transport remains an unresolved issue 
in oral tolerance induction. In general, the port of entry into 
the body creates a bias in the reactivity toward an antigen 
among the diverse lymphoid compartments. Thus, after 
adoptive transfer of TCR-transgenic T cells, antigen-specifi  c 
proliferation of these cells can be induced more effi   ciently in 
spleen and pLN than in MLN when low doses of antigen are 
injected into the tail vein (Fig. S1, available at http://www.
jem.org/cgi/content/full/jem.20052016/DC1). In contrast, 
oral administration of a 1,000-fold higher antigen dose fails to 
induce de novo T cell proliferation of antigen-specifi  c T cells 
in peripheral lymphoid organs (Fig. 1 and not depicted). 
  Interestingly, we observed that this lack of antigen recognition in
peripheral lymphoid organs after antigen feeding is   sustained 
in mice that underwent mesenteric lymphadenectomy (Fig. 5). [ID]FIG5[/ID 
In such animals, within 5 wk after surgery, pseudo-aff  erent 
lymph vessels emerged that would permit the direct transfer of 
antigen being passively drained from the intestine into the 
  circulation. Regardless of the presence or absence of MLN, 
free antigen entering the blood circulation after feeding (14) 
rem  ains immunologically inconspicuous possibly because it 
might be diluted below threshold levels required for antigen 
recognition in the peripheral lymphoid organs.
Induction of T cell proliferation in MLN and induction 
of oral tolerance upon antigen feeding depend on CCR7
A key regulator of immune cell traffi   cking is the chemokine 
receptor CCR7 that is abundantly expressed by subsets of 
T cells and DCs (25). We have previously reported that skin 
DCs that lack functional CCR7 fail to migrate to the drain-
ing LNs (26), most likely a result of their inability to enter 
  aff  erent lymphatics. We thus analyzed the proliferation of 
adoptively transferred antigen-specifi  c T cells in wild-type 
and CCR7-defi  cient recipients after antigen feeding. As ex-
pected, a robust T cell proliferation was induced in MLN and 
Figure 4.  Oral administration of antigen does not induce prolif-
eration of antigen-specifi  c T cells in transplanted PP and MLN that 
are connected to the host circulation but not to afferent lymphatics 
of the host intestine. Intestinal segments together with completely 
intact donor MLN were transplanted into syngenic wild-type recipients. 
Grafts were connected to the host blood circulation and both graft ends 
were exteriorized as stomata. Subsequently, recipient mice were adop-
tively transferred with 107 CFSE-labeled OTII cells. 2 d after feeding of 
100 mg ovalbumin (oral), proliferation of ovalbumin-specifi  c TCR-trans-
genic T cells occurred only in endogenous but not in transplanted organs, 
whereas systemic administration of antigen by intravenous injection (i.v.) 
resulted in comparable reactions in grafted and host gut-associated lym-
phoid tissue. Note that naive transgenic cells were present in the grafted 
MLN/PP, indicating a successful coupling to the recipients’ lymphocyte 
recirculation. Dot plots are gated on Vα2/Vβ5-positive lymphocytes.JEM VOL. 203, March 20, 2006  523
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PP of wild-type recipients, but not in pLN and spleen 2 d 
  after antigen feeding (see also results presented in Fig. 1). 
In contrast, in CCR7-defi  cient recipients, almost no prolif-
eration of adoptively transferred transgenic T cells was ob-
served in any of the organs analyzed except in PP (Fig. 6 A 
and not depicted), whereas intravenous antigen injection re-
sulted in comparable levels of T cell proliferation in MLN of 
both wild-type and CCR7-defi  cient mice (not depicted and 
<CIT>reference 26</CIT>).[ID]FIG6[/ID Similar results were observed in plt/plt mice 
that lack the CCR7 ligands CCL19 and CCL21-Ser (Fig. 6 
A and not depicted). CCR7-defi  cient mice possess normal 
numbers of PP (not depicted) and harbor unaltered popula-
tions of DCs in the LP compared with wild-type mice (Fig. 
6 B), suggesting that the uptake of intestinal antigens should 
not be altered in these mutants. In consequence, the role of 
CCR7-mediated cell migration in oral tolerance induction 
can be explored in CCR7-defi  cient mice. To this aim, we 
fed ovalbumin to CCR7-defi  cient and wild-type mice under 
tolerogenic conditions. Importantly, we failed to observe in-
duction of oral tolerance in CCR7-defi  cient mice (Fig. 6 C). 
Assuming that an important path for tolerance induction re-
lies on soluble antigens being passively drained into the MLN, 
in CCR7 mutant mice these antigens would meet LN-resident 
DCs that are dramatically reduced in numbers (Fig. 6 B) 
and possibly defective in function as a result of misplacement 
(not depicted), wherefore tolerance induction possibly fails 
to occur. However, as mentioned earlier in this paragraph, 
the mere presence of soluble antigen diff  used into the MLN 
via the bloodstream after intravenous administration elicits a 
  vigorous T cell response in CCR7-defi  cient organs, demon-
strating the MLN’s unhindered capability to drive T cell 
responses (unpublished data and  <CIT>reference 26 </CIT>). These obser-
vations establish a decisive role for CCR7-dependent cell 
migration from the intestine to the draining MLN in oral 
tolerance induction. Additionally, we observed that the ho-
meostatic migration of LP DCs stringently depends on CCR7. 
Intestinal LP DCs express the αE-integrin chain CD103 and 
MLN resident CD103+ DCs derived from the LP are capable 
of imprinting intestinal homing on T cells (27). In CCR7-
defi  cient mice, the frequency of these LP-derived DCs in 
MLN is selectively reduced compared with CD103− DCs 
(18 ± 7% CD103+ DCs in CCR7-defi  cient mice compared 
with 46 ± 12% CD103+ DC in wild-type mice, mean ± SD, 
n = 6 in each group). In contrast, the frequency of CD103+ 
DCs is unchanged in the LP, indicating that the homeostatic 
migration of CD103+ DCs from the intestine into MLN is 
governed by CCR7 signaling.
D  I  S  C  U  S  S  I  O  N 
Circumstantial evidence fostered the widely accepted con-
cept that the foundation of oral tolerance induction is laid in 
all the lymphoid tissues present in an organism. We reevalu-
ated this process, dissecting it into the following crucial steps: 
(a) surgical manipulations removing the MLN or grafting 
MLN, including intestines, to investigate the importance of 
MLN and direct intestinal-to-MLN transport of antigen, 
  respectively; (b) applying the drug FTY720, thus preventing 
regular T cell homeostasis; and (c) analyzing CCR7-defi  cient 
mice known for their disturbed DC balance and migration.
Our combined data obtained by these experimental ap-
proaches would favor the hitherto unrecognized hypothesis 
that oral tolerance induction relies solely on mechanisms 
  restricted to cells residing in the intestinal immune system. 
In particular, the MLN are privileged in triggering oral toler-
ance because their removal results in devastating consequences 
with respect to oral tolerance induction. The importance of 
MLN for oral tolerance induction is also supported by the 
fi  ndings of others, demonstrating that the reconstitution of 
MLN by an agonistic anti-lymphotoxin–β-receptor antibody 
is suffi   cient to regain the capability to induce oral tolerance in 
lymphotoxin-α–defi  cient mice (7). In contrast, PP and further 
M cell–competent compartments of gut-associated lymphoid 
tissue such as solitary intestinal lymphoid tissue (4) cannot com-
pensate for defi  cits in oral tolerance induction caused by the 
absence of MLN (5, 6). A similar reasoning also holds true for 
the liver that, in addition to classical lymphoid organs, has been 
suggested to be required for oral tolerance induction (28).
Grafted MLN that do not receive eff  erent lymph drained 
from the antigen-challenged intestine react like any distal 
pLN in respect to their capability to drive T cell proliferation. 
This suggests that the special role of MLN in oral tolerance 
Figure 5.  Mesenteric lymphadenectomy does not result in antigen 
recognition in peripheral lymphoid organs after oral administration 
of antigen. 5 wk after mesenteric lymphadenectomy, MLN-explanted 
mice (−MLN) and unmanipulated wild-type controls (+MLN) were adop-
tively transferred with 107 CFSE-labeled DO11.10 cells. Oral administration 
of 100 mg ovalbumin 1 d later did not result in proliferation of ovalbumin-
specifi  c TCR-transgenic T cells in pLN and spleen 2 d after feeding, 
  irrespective of the presence of the MLN. Dot plots are gated on DO11.10 
TCR-positive lymphocytes.524  ORAL TOLERANCE INDUCTION | Worbs et al.
induction relies on aff  erent lymph drained from the intestine 
and entering these particular LNs. Apparently, antigen pass-
ing through the intestinal tract and being taken up into the 
circulation (14) does not manifest its presence inside the body 
by triggering T cell responses in spleen and pLN. Therefore, 
these results imply that the recognition of fed antigen is 
strictly confi  ned to the intestinal immune system. Conse-
quently, the appearance of divided cells in distal organs in the 
absence of FTY720 is most likely the result of the peripheral 
dissemination of cells that have fi  rst been activated in the in-
testinal immune system.
It is generally accepted that oral tolerance induction may 
involve either anergy or deletion of T cells, or the induction 
of regulatory T cells. Although the precise contribution of 
these mechanisms to oral tolerance induction is unknown, 
high doses of antigen tend to favor deletion and anergy, 
whereas low doses seem to generate predominantly regula-
tory T cells (29). Interestingly, we observed that oral toler-
ance can be induced in mice in the absence of lymphocyte 
recirculation using a high dose feeding regimen. Under these 
conditions, a substantial pool of antigen-specifi  c T cells is 
trapped in the periphery, preventing antigen recognition by 
Figure 6.  (A) Induction of T cell proliferation in MLN upon antigen 
feeding depends on CCR7. Wild-type, plt/plt, and CCR7-defi  cient mice 
were adoptively transferred with 107 CFSE-labeled OTII cells and fed 
100 mg ovalbumin 1 d later. Proliferation of ovalbumin-specifi  c T cells in 
MLN was analyzed 2 d after antigen administration. Dot plots are gated 
on Vα2/Vβ5-positive lymphocytes. In contrast with wild-type mice, no 
induction of T cell proliferation occurred in MLN of plt/plt mutants and 
CCR7-defi  cient animals. (B) Analysis of DCs in LP and MLN. DCs in the LP 
and MLN of wild-type (white bars) and CCR7-defi  cient mice (black bars) 
were analyzed by fl  ow cytometry and immunofl  uorescent microscopy. 
No significant differences in the number and phenotype of DCs 
were observed in the LP, whereas MLN of CCR7 mutants harbored severely 
decreased numbers of DCs compared with wild-type mice. (C) Oral toler-
ance induction is impaired in CCR7-defi  cient mice. Wild-type and CCR7-
defi  cient mice were fed 25 mg ovalbumin (black bars) on days 0 and 2 or 
mock treated (white bars). Subsequently, on day 9, mice were immunized 
by intraperitoneal injection of ovalbumin in PBS/CFA emulsion and chal-
lenged on day 22 (see Materials and methods). Tolerance induction was 
analyzed by measurement of DTH reactions 48 h after challenge. Data 
shown have been obtained with the following: n = 7 wild-type mice 
(PBS); n = 9 wild-type mice (Ova); n = 11 CCR7−/− mice (PBS); n = 12 
CCR7−/− mice (Ova). Error bars represent SD in B and SEM in C.JEM VOL. 203, March 20, 2006  525
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these cells. Yet tolerance is maintained after full reconstitu-
tion of lymphocyte homeostasis, indicating that potentially 
reactive T cells are held in check. Consequently, this obser-
vation suggests a decisive role for regulatory T cells in a high-
dose feeding regimen. We hypothesize that, once initiated in 
the intestinal immune system, the knowledge of tolerance is 
communicated shortly thereafter to the periphery by T cells 
disseminating into distal LNs and spleen.
In addition, our observations suggest that immunologically 
relevant food antigens need to be transported into the MLN 
via aff  erent lymph, most likely by LP-resident DCs. Oral tol-
erance cannot be induced in CCR7-defi  cient mice, although 
CCR7-defi  cient lymphoid organs are competent to drive 
T cell proliferation upon systemic antigen administration. This 
implies a decisive contribution of unimpaired cell-bound anti-
gen transport by DCs migrating from the intestine into MLN. 
Importantly, free antigen passively drained from the intestine 
and entering the MLN appears to remain immunologically in-
conspicuous and does not elicit T cell proliferation in MLN. 
Notably, this scenario is reminiscent to the situation of antigen 
entering the circulation without initiating T cell proliferation 
in pLN and spleen. In support of this hypothesis, it was ob-
served that, after antigen feeding, DCs collected from the tho-
racic duct of lymph-adenectomized rats are able to stimulate 
T cells in vitro and in vivo (30). Furthermore, DCs in the in-
testine have been reported to present orally applied antigens 
(10), and expansion of the DC pool by treatment with Flt3-
  ligand facilitates the induction of oral tolerance (31). Oral tol-
erance inducing DCs entering the MLN might originate from 
organized lymphoid structures (PP, solitary intestinal lymphoid 
tissue) or alternatively the LP. However, PP residing at the 
frontline of antigen uptake (i.e., the intestinal mucosa) are not 
essential for oral tolerance induction (5) and the majority of DCs 
entering the MLN has been proposed to originate from the LP 
(11, 12), suggesting that predominantly LP-derived DCs 
  contribute to oral tolerance induction.
In conclusion, our results reveal that food antigen receives 
immunological attention exclusively in the intestinal immune 
system. Consequently, establishment of systemic tolerance to 
food antigens is inevitably bound to its origin in the intestinal 
immune system. These results call for a shift in the basic un-
derstanding of how the immune system manages tolerance 
and indicate that intestinal DCs are potential targets for both 
the therapeutic use of oral tolerance and the prevention of 
tolerance against oral vaccines.
MATERIALS AND METHODS
Animals. BALB/c, C57BL/6, C57BL/10, C57BL/6 OTII, C57BL/6 
CCR7−/−, C57BL/6 plt/plt, and BALB/c DO11.10 were bred at the cen-
tral animal facility of the Hannover Medical School under specifi  c pathogen-
free conditions; BALB/c and C57BL/6 mice were also purchased from 
Charles River Laboratories. All animal experiments have been performed in 
accordance with the institutional guidelines and have been approved by the 
institutional review board of the Hannover Medical School.
Antibodies. The following antibodies and conjugates were used in this 
study: anti-CD4–PerCp, anti-CD8α–allophycocyanin–Cy7, anti-CD11b–
PE-Cy7, anti-CD11c–PE, anti-CD11c– allophycocyanin, anti-CD11c–bio, 
anti-CD103–PE, anti-MHCII (I-Ab)–FITC, anti-MHCII (I-Ab)–bio, anti-
Vα2–PE, anti-Vβ5–bio (BD Biosciences), anti-CD8α–bio, and anti-
DO11.10 TCR–Cy5 (clone KJ1-26; Caltag). Anti-CD3 (clone 17A2) and 
anti-CD4 (clone RMCD4) antibodies were provided by E. Kremmer (GSF 
München, Munich, Germany). Cy5 conjugates of anti-CD3 and anti-CD4 
antibodies were prepared as recommended by the manufacturer (GE Health-
care). Biotinylated antibodies were recognized by streptavidin coupled to 
Cy3, PE (Jackson ImmunoResearch Laboratories), Alexa 405 (Invitrogen), 
or PerCp (BD Biosciences).
Immunohistochemistry. Immunohistochemistry was performed accord-
ing to standard protocols. In brief, sections were rehydrated in TBST (0.1 M 
Tris, pH 7.5, 0.15 M NaCl, 0.1% Tween 20), preincubated with TBST 
containing 5% rat or mouse serum, blocked with 0.001% avidin/PBS and 
0.001% biotin/PBS, and stained with a cocktail of biotinylated or fl  uorescent 
dye–coupled antibodies in 2.5% serum/TBST. Biotinylated antibodies were 
visualized by fl  uorescent streptavidin conjugates. Nuclei were visualized by 
DAPI staining (1 μg/ml DAPI/TBST) and sections were mounted with 
MOWIOL. Images were acquired using an Axiovert 200 M microscope 
with Axiovision software (Carl Zeiss MicroImaging, Inc.).
Flow cytometry. To obtain single cell suspensions of pLN (inguinal, bra-
chial, and axillary LNs), MLN, and PP, organs were minced through a nylon 
mesh and washed with PBS supplemented with 2% FCS. For the isolation of 
LP cells, gut content and PP were removed before intestines were opened 
longitudinally. Intestines were washed twice in cold PBS and once in cold 
PBS/5% FCS/5 mM EDTA, and incubated twice in 25 ml RPMI 1640 me-
dium/5% FCS/5 mM EDTA at 37°C to remove the epithelial cell fraction. 
The remaining tissue was washed with PBS, cut into small pieces, and incu-
bated at 37°C for 45 min in RPMI 1640/20% FCS/0.5 mg/ml collagenase 
A (Roche). The resulting suspension was fi  ltered through a nylon mesh, 
pelleted, and resuspended in 40% Percoll (GE Healthcare) in RPMI 1640/5% 
FCS. This cell suspension was overlaid onto 70% Percoll in RPMI 1640/5% 
FCS and centrifuged at 800 g for 20 min. LP cells were recovered from the 
interphase and washed twice in PBS/2% FCS before staining with the anti-
bodies described. FACS analysis was performed on a FACSCalibur or LSRII 
(both obtained from BD Biosciences).
Intestinal surgery. Mouse-vascularized small bowel transplantation was 
performed as described previously (32) with some modifi  cations. C57BL/10 
mice were used as donors and recipients. In brief, under the combined anes-
thesia with Ketamine and Rompun, the donor jejunum and proximal ileum 
together with the MLN were isolated with the superior mesenteric artery 
and portal vein attached. After luminal irrigation and vascular perfusion, the 
graft was stored at 4°C in Ringer’s solution until implantation. The graft 
portal vein and superior mesenteric artery were anastomosed to the recipi-
ent’s inferior vena cava and abdominal aorta, respectively, in an end-to-side 
fashion. Both ends of the graft were exteriorized as stomata. Mesenteric 
lymphadenectomy was performed by microdissection along the length of the 
superior mesenteric artery to aortic root (33). To confi  rm completeness of 
mesenteric lymphadenectomy, animals received 150 μL Chicago sky blue 
(Sigma-Aldrich) solution (1% in PBS) by intraperitoneal injection at the end 
of the experiment. 10 d later, mice were killed and carefully inspected to re-
veal remaining MLN.
FTY720 treatment. Mice received 1 mg/kg body weight of FTY720 dis-
solved in PBS by gavage every second day. Eff  ect of FTY720 treatment was 
monitored by regular analysis of peripheral blood lymphocyte counts.
Adoptive transfer of CFSE-labeled lymphocytes. Either BALB/c 
DO11.10 (Figs. 1 and 5) or C57BL/6 OTII (Figs. 4 and 6 A) mice were used 
as cell donors for adoptive transfer into syngenic recipient animals. Lympho-
cytes were isolated from pLN (inguinal, brachial, and axillary), MLN, and 
spleen and labeled with 5 μM CFSE (Invitrogen) for 15 min at 37°C. 526  ORAL TOLERANCE INDUCTION | Worbs et al.
After washing twice with PBS/3% FCS, 107 cells per mouse were injected 
into the lateral tail vein.
Antigen-feeding regimen. For analyzing the proliferation of ovalbumin-
specifi  c transgenic T cells, mice were fed 100 mg ovalbumin (Grade III; 
Sigma-Aldrich) in 200 μl PBS by gavage above the lower esophageal sphinc-
ter with a stainless steel feeding needle on day 0. For the measurement of 
DTH responses, mice were fed 25 mg ovalbumin (Grade III, Sigma-Aldrich) 
in 200 μl PBS on days 0, 3, 6, and 8 (Fig. 2) or on days 0 and 2 (Figs. 3 and 6). 
In some experiments, cessation of antigen presentation was verifi  ed by adop-
tive transfer of CFSE-labeled DO11.10 transgenic T cells into wild-type 
“reporter” mice at diff  erent time points after antigen feeding. 2 d after T cell 
transfer, animals were killed and proliferation of transgenic T cells was deter-
mined by fl  ow cytometry. Absence of T cell proliferation indicated cessation 
of functional antigen recognition.
Immunization. Mice were immunized by subcutaneous (Figs. 2 and 3) or 
intraperitoneal (Fig. 6 C) injection of 300 μg ovalbumin (Grade VI; Sigma-
Aldrich) in 200 μl PBS/CFA emulsion (containing 100 μg MT; Sigma-
  Aldrich) on day 28 (Fig. 2), day 21 (Fig. 3), or day 9 (Fig. 6 C) after the fi  rst 
oral ovalbumin dose.
Induction and measurement of DTH responses. 13 d after immuniza-
tion, mice were challenged by subcutaneous injection of 50 μg ovalbumin 
(Grade VI; Sigma-Aldrich) in 20 μl PBS into the right ear pinna while 20 μl 
PBS without ovalbumin were injected into the left ear pinna for control 
purposes. Ear swelling was measured in a blinded fashion before and 48 h 
  after injection with a custom-built spring driven micrometer. Ovalbumin-
specifi  c ear swelling was calculated as the following: (right ear thickness − 
left ear thickness)48h − (right ear thickness − left ear thickness)0h. None of 
the animals used for the measurement of DTH responses had received adop-
tively transferred cells.
Statistical analysis. Statistical analysis was performed with the commercially 
available software GraphPadPrism. All signifi  cant values were determined us-
ing the unpaired two-tailed nonparametric Mann-Whitney-test, error bars 
represent SD (Fig. 6 B) and SEM (Figs. 2, 3, and 6 C), respectively.
Online supplemental material. Fig. S1 shows that MLN are less eff  ective 
than peripheral lymphoid tissues in supporting T cell proliferation after in-
travenous injection of antigen. Online supplemental material is available at 
http://www.jem.org/cgi/content/full/jem.20052016/DC1.
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